Pondering vexing issues in infection prevention and control
Sunday, June 28, 2009
New MRSA bill in Congress
The MRSA Infection Prevention and Patient Protection Act was recently introduced into both the US House of Representatives and Senate. The bill mandates testing for MRSA on admission and discharge from the ICU and other high risk units. We can only hope that CDC is able to influence the lawmakers by bringing MRSA into perspective. If not, the winners will be the companies who make the MRSA testing products. The losers will be hospital infection control programs, which are already overworked and underresourced, and the patients these programs serve.
Subscribe to:
Post Comments (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
Back on clinical service again and having more thoughts on poor hospital design. Last month I wondered why there were no stethoscope wipe...
-
Those that follow me on twitter or the blog have probably noticed my recent focus on trying to understand the emergence of compulsory influe...
-
REUTERS/Athit Perawongmetha With the assistance of a great supply management team, we have been able to outfit all of our clinical staff wit...
No comments:
Post a Comment
Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.